Discover
RANI
Rani Therapeutics Holdings, Inc.
0.77
2 x 0.53
2 x 0.98
bid
ask
+
0.01
1.05%
2 @ 04:00 PM
0.77 +0.00 (0.21%)
| Ytd | -43.08% | |
| 1y | 49.49% |
0.75
day range
0.78
0.39
52 week range
3.87
| Open | 0.77 | Prev Close | 0.76 | Low | 0.75 | High | 0.78 | Mkt Cap | 105.64M |
| Vol | 471.43K | Avg Vol | 891.01K | EPS | -0.27 | P/E | N/A | Forward P/E | -1.41 |
| Beta | 0.11 | Short Ratio | 0.36 | Inst. Own | 19.59% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 0.89 | 200-d Avg | 1.18 | 1yr Est | 11.50 |
| Income Statement | |||
| Total Revenue | 1.71M | ||
| Revenues (USD) | 1.71M | ||
| Gross Profit | 1.71M | ||
| Operating Expenses | 10.05M | ||
| Research and Development Expense | 5.16M | ||
| Selling, General and Administrative Expense | 4.89M | ||
| Operating Income | -8.34M | ||
| Interest Expense | 88.00K | ||
| Net Income | -7.03M | ||
| Net Income Common Stock | -7.03M | ||
| Net Income Common Stock (USD) | -7.03M | ||
| Consolidated Income | -8.01M | ||
| Net Income to Non-Controlling Interests | -982.00K | ||
| Earnings per Basic Share | -0.04 | ||
| Earnings per Basic Share (USD) | -0.04 | ||
| Earnings per Diluted Share | -0.04 | ||
| Earning Before Interest & Taxes (EBIT) | -6.94M | ||
| Earning Before Interest & Taxes (USD) | -6.94M | ||
| Weighted Average Shares | 180.00M | ||
| Weighted Average Shares Diluted | 180.00M | ||
| Balance Sheet | |||
| Cash and Equivalents | 9.64M | ||
| Cash and Equivalents (USD) | 9.64M | ||
| Investments | 33.76M | ||
| Investments Current | 33.76M | ||
| Trade and Non-Trade Receivables | 2.04M | ||
| Current Assets | 47.09M | ||
| Property, Plant & Equipment Net | 4.54M | ||
| Total Assets | 51.88M | ||
| Debt Current | 1.46M | ||
| Total Debt | 3.94M | ||
| Current Liabilities | 13.86M | ||
| Debt Non-Current | 2.48M | ||
| Total Liabilities | 16.34M | ||
| Accumulated Retained Earnings (Deficit) | -139.61M | ||
| Accumulated Other Comprehensive Income | -8.00K | ||
| Shareholders Equity | 28.41M | ||
| Shareholders Equity (USD) | 28.41M | ||
| Assets Non-Current | 4.79M | ||
| Total Debt (USD) | 3.94M | ||
| Deferred Revenue | 6.83M | ||
| Liabilities Non-Current | 2.48M | ||
| Trade and Non-Trade Payables | 858.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 638.00K | ||
| Net Cash Flow from Financing | -27.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -8.97M | ||
| Capital Expenditure | -15.00K | ||
| Issuance (Purchase) of Equity Shares | 5.00K | ||
| Net Cash Flow from Investing | -2.45M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -2.43M | ||
| Net Cash Flow from Operations | -6.50M | ||
| Share Based Compensation | 2.08M | ||